|
Delaware
|
82-1895605
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
1300 So. El Camino Real, Suite 400
San Mateo, California
|
94402
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Large accelerated filer
|
☐
|
Smaller reporting company
|
☒
|
|
Non-accelerated filer
|
☒
|
Accelerated filer
|
☐
|
|
Emerging growth company
|
☐
|
|
ITEM 3.
|
INCORPORATION OF DOCUMENTS BY REFERENCE.
|
| • |
the registrant's Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March
21, 2024;
|
| • |
the registrant's Current Reports on Form 8-K, filed with the SEC on January
25, 2024, March 5, 2024 and March 7,
2024;
|
| • |
the description of the registrant's common stock contained in Exhibit 4.4 of the registrant's Annual Report on Form 10-K, filed with the SEC on February 24, 2022,
including any amendments or reports filed for the purpose of updating such description.
|
| ITEM 8. |
EXHIBITS.
|
|
Exhibit
Number
|
Description
|
|
|
4.1
|
||
|
4.2
|
||
|
4.3
|
||
|
5.1
|
||
|
23.1
|
||
|
23.2
|
Consent of Cooley LLP. Reference is made to Exhibit 5.1.
|
|
|
24.1
|
Power of Attorney. Reference is made to the signature page hereto.
|
|
|
99.1
|
||
|
99.2
|
||
|
107
|
||
|
KRONOS BIO, INC.
|
||
|
By:
|
/s/ Norbert Bischofberger
|
|
|
Norbert Bischofberger, Ph.D.
|
||
|
President and Chief Executive Officer
|
||
|
Signature
|
Title
|
Date
|
||
|
/s/ Norbert Bischofberger
|
President, Chief Executive Officer and Director
|
March 21, 2024
|
||
|
Norbert Bischofberger, Ph.D.
|
(Principal Executive Officer)
|
|||
|
/s/ Sandra A. Gardiner
|
Interim Chief Financial Officer
|
March 21, 2024
|
||
|
Sandra A. Gardiner
|
(Principal Financial and Accounting Officer)
|
|||
|
/s/ Arie Belldegrun
|
Chair of the Board of Directors
|
March 21, 2024
|
||
|
Arie Belldegrun, M.D. FACS
|
||||
|
/s/ Roshawn Blunt
|
Director
|
March 21, 2024
|
||
|
Roshawn Blunt
|
||||
|
/s/ Roger Dansey
|
Director
|
March 21, 2024
|
||
|
Roger Dansey, M.D.
|
||||
|
/s/ Joshua Kazam
|
Director
|
March 21, 2024
|
||
|
Joshua Kazam
|
||||
|
/s/ Elena Ridloff
|
Director
|
March 21, 2024
|
||
|
Elena Ridloff, CFA
|
||||
|
/s/ Katherine Vega Stultz
|
Director
|
March 21, 2024
|
||
|
Katherine Vega Stultz
|
||||
|
/s/ David Tanen
|
Director
|
March 21, 2024
|
||
|
David Tanen
|
||||
|
/s/ Taiyin Yang
|
Director
|
March 21, 2024
|
||
|
Taiyin Yang, Ph.D.
|